Annie Guérin

Managing Principal
Annie Guérin
Montreal

Education

M.S. and B.S., economics, Université de Sherbrooke

Summary of Experience

Ms. Guérin is a health economist specializing in health economics and outcomes research (HEOR) and real-world evidence. She designs and leads retrospective database studies (claims, electronic health records, registries, and unstructured physician notes), large-scale multi-country chart reviews and surveys, and economic models to inform clinical, policy, and market-access decisions. She has deep expertise in data curation, linkage, and quality assessment across disparate datasets, and applies advanced statistical methods to generate robust, credible evidence. Her methodological work spans comparative and cost effectiveness, patient-reported and preference research, burden of illness, treatment patterns, safety analyses, and predictive modeling, using machine learning and AI to advance risk prediction, patient stratification, treatment optimization, and early identification of unmet needs.

Therapeutic experience includes oncology, hematology, hepatology, dermatology, gastroenterology, rheumatology, neurology, psychiatry, endocrinology, cardiology, and respiratory disease. Ms. Guérin leads HEOR strategy and global evidence generation planning for biopharmaceutical partners, supporting both regulatory (US Food and Drug Administration (FDA) and European Medicines Agency) and payer decision making through value communication materials. She is recognized for developing international, large-scale evidence-generation strategies that balance scientific rigor with real-world feasibility. Ms. Guérin has authored over 100 peer-reviewed publications, frequently presents at scientific conferences, and contributes to advancing HEOR and real-world evidence methodologies.

En Français

Annie Guérin
Practices